RxDoctor Payments Data

Heeren Makanji, MD

Orthopaedic Surgery · Hartford, CTNPI 1083052633

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. Globus Medical accounts for 78.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,620 and has fallen 92.4% since, to $351 in 2025.

$10,102in general payments, 2019–2025

Across 217 payments — averaging $46.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$8K
  • Zimmer Biomet$548
  • Johnson & Johnson$502
  • Stryker$375
  • Si-bone, Inc.$166
  • Medtronic$142
  • plus $423 from 6 others
$186,852in research payments, 2019–2025

Across 49 payments — averaging $3813.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$88K
  • Ossdsign USA Incorporated$51K
  • Globus Medical$48K

What the payments were for

  • Travel & lodging$4,53045%
  • Food & beverage$5,05650%
  • Education$5165%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,102 in reported general payments places this provider in the 75th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$145,847
Medicare patients
308
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin171$2,202
Methocarbamol169$1,494
Pregabalin47$1,049
Lidocaine17$956
Tizanidine Hcl76$937
Baclofen71$778
Celecoxib35$515
Methylprednisolone63$383
Ibuprofen22$376
Meloxicam98$289
Tramadol Hcl66$283
Levetiracetam14$276
Cyclobenzaprine Hcl30$242
Duloxetine Hcl14$236
Topiramate44$236

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →